(PDF) Patients With III and IV Category of the Bethesda

Patients With III and IV Category of the Bethesda System Under Levothyroxine Non-Suppressive Therapy Have a Lower Rate of Thyroid Malignancy

Scientific Reports - United Kingdom

doi 10.1038/s41598-019-44931-8

Full Text

Open PDF

Abstract

Available in full text

Date

June 10, 2019

Authors

Krzysztof Kaliszewski

Dorota Diakowska

Beata Wojtczak

Krzysztof Sutkowski

Bartłomiej Knychalski

Zdzisław Forkasiewicz

Publisher

Springer Science and Business Media LLC

Related search

Thyroid Cancer Detection Rate and Associated Risk Factors in Patients With Thyroid Nodules Classified as Bethesda Category III

Radiology and Oncology

English

Malignancy Rates for Bethesda III and IV Thyroid Nodules: A Retrospective Study of the Correlation Between Fine-Needle Aspiration Cytology and Histopathology

BMC Endocrine Disorders

English

Exercise Is Associated With Better Quality of Life in Patients on TSH-suppressive Therapy With Levothyroxine for Differentiated Thyroid Carcinoma

Arquivos Brasileiros de Endocrinologia & Metabologia

2014

English

Hemithyroidectomy Seems to Be a Reasonable Initial Surgical Approach for Patients With Cytologically Bethesda Category III (AUS/FLUS) Thyroid Nodules

Endocrine Abstracts

2016

English

Thyroid Cytology-Nuclear Versus Architectural Atypia Within the “Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance” Bethesda Category Have Significantly Different Rates of Malignancy

English

The Diagnostic Performance of Thyroid US in Each Category of the Bethesda System for Reporting Thyroid Cytopathology

PLoS ONE

Multidisciplinary

2016

English

Does the Bethesda Category Predict Aggressive Features in Differentiated Thyroid Cancer?

Archives of endocrinology and metabolism

English

The Bethesda System for Reporting Thyroid Cytopathology

English

Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features (NIFTP): Implications for the Risk of Malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)

English

Amanote Research

Patients With III and IV Category of the Bethesda System Under Levothyroxine Non-Suppressive Therapy Have a Lower Rate of Thyroid Malignancy

Scientific Reports - United Kingdom

doi 10.1038/s41598-019-44931-8

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Thyroid Cancer Detection Rate and Associated Risk Factors in Patients With Thyroid Nodules Classified as Bethesda Category III

Malignancy Rates for Bethesda III and IV Thyroid Nodules: A Retrospective Study of the Correlation Between Fine-Needle Aspiration Cytology and Histopathology

Exercise Is Associated With Better Quality of Life in Patients on TSH-suppressive Therapy With Levothyroxine for Differentiated Thyroid Carcinoma

Hemithyroidectomy Seems to Be a Reasonable Initial Surgical Approach for Patients With Cytologically Bethesda Category III (AUS/FLUS) Thyroid Nodules

Thyroid Cytology-Nuclear Versus Architectural Atypia Within the “Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance” Bethesda Category Have Significantly Different Rates of Malignancy

The Diagnostic Performance of Thyroid US in Each Category of the Bethesda System for Reporting Thyroid Cytopathology

Does the Bethesda Category Predict Aggressive Features in Differentiated Thyroid Cancer?

The Bethesda System for Reporting Thyroid Cytopathology

Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features (NIFTP): Implications for the Risk of Malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)